Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preliminary outcomes of preemptive warfarin pharmacogenetic testing at a large rural healthcare center.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists - 21 Feb 2019

Leary Emili, Brilliant Murray, Peissig Peggy, Griesbach Sara

Abstract excerpt

PURPOSE: As a preliminary evaluation of the outcomes of implementing pharmacogenetic testing within a large rural healthcare system, patients who received pre-emptive pharmacogenetic testing and warfarin dosing were monitored until June 2017. SUMMARY: Over a 20-month period, 749 patients were genotyped for VKORC1 and CYP2C9 as part of the electronic Medical Records and Genomics Pharmacogenetics (eMERGE PGx)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Monitoring
Share to Hemorrhage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to International Normalized Ratio

Share to Pharmacogenomic Testing

Share to Pharmacogenomic Variants

Share to Program Evaluation

Share to Thromboembolism

Share to Warfarin

Source

Open in PubMed Open full text

Identifiers

PMID: 31415684
DOI: 10.1093/ajhp/zxy072
PMCID: PMC6479622

Genes

CYP2C9
VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preliminary outcomes of preemptive warfarin pharmacogenetic testing at a large rural healthcare center.PMID 31415684Read ↗

Efficacy of Warfarin Therapy Guided by Pharmacogenetics: A Real-world Investigation Among Han Taiwanese.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.Semantic proximity Read ↗

A regulatory science perspective on warfarin therapy: a pharmacogenetic opportunity.Semantic proximity Read ↗

A randomized trial of genotype-guided dosing of warfarin.Semantic proximity Read ↗

Warfarin pharmacogenomics: recommendations with available patented clinical technologies.Semantic proximity Read ↗

Role of Warfarin Pharmacogenetic Testing in Clinical PracticeSemantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.Semantic proximity Read ↗

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.Semantic proximity Read ↗

Implementation of CYP2C19 and CYP2D6 genotyping to guide antidepressant use in a large rural health system.Semantic proximity Read ↗

Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activitySemantic proximity Read ↗

Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach.Semantic proximity Read ↗

Medication review with follow-up service by community pharmacists forpatients under treatment with coumarin anticoagulants in collaboration with Primary CareSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.